Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

IGF-1

Insulin-like Growth Factor 1, Somatomedin C

A 70-amino acid hormone that promotes cell growth, proliferation, and survival, primarily produced in the liver in response to growth hormone stimulation.

Molecular Profile
Formula C331H512N94O101S7
Mol. Weight 7649 g/mol
Sequence Gly-Glu-Pro-Pro...
Route
Subcutaneous (SC)
40-120 mcg/kg twice daily
SUB
Intravenous (IV)
40 mcg/kg/hour infusion
INT

How It Works

How It Works: IGF-1 acts as an anabolic hormone by binding to specific receptors on cell surfaces, activating signaling pathways that enhance cell growth, metabolism, and survival.

  • Receptor Activation: Binds to IGF-1 receptor (IGF-1R), a tyrosine kinase, causing autophosphorylation and downstream signaling.
  • PI3K-Akt Pathway: Promotes cell survival, inhibits apoptosis, and regulates glucose metabolism.
  • MAPK/ERK Pathway: Stimulates cell proliferation, differentiation, and protein synthesis.
  • Cross-talk with Insulin: At high levels, binds to insulin receptors, mimicking insulin's effects on glucose uptake.

Latest Clinical Trials

Completed PHASE1 NCT00882674

A Study to Evaluate the Biological Activity of R1507 in Women With Operable Breast Cancer

Hoffmann-La Roche
INTERVENTIONAL
Updated Dec 15, 2025
Terminated NCT02698384

Therapeutic Strategies in Acromegalic Subjects Treated With Lanreotide 120mg

Ipsen
OBSERVATIONAL
Updated Dec 15, 2025
Completed NA NCT07100587

Ketogenic vs. Mediterranean Diet on Metabolic and Hormonal Parameters in Patients With Active Acromegaly

University of Palermo
INTERVENTIONAL
Updated Dec 15, 2025
View All Clinical Trials

Latest Studies

Utility 1
pubmed Dec 10, 2025

Long-term clinical control in acromegaly patients with postoperative discordant nadir growth hormone during oral glucose tolerance test and insulin-like growth factor 1 levels: a retrospective observational study and literature review.

Ishida. Tomohisa T; Kawaguchi. Tomohiro T; Ogawa. Yoshikazu Y; Endo. Hidenori H

The study looked at people who had surgery for a hormone‑overproduction tumor (acromegaly) and found that even when lab tests for growth hormone and IGF‑1 didn’t match, most patients stayed stable without extra treatment for many years.

Utility 3
pubmed Dec 9, 2025

Association between vertebral fracture risk and bone mineral density in patients with acromegaly.

Chen. Shuaiming S; Liu. Min M; Tan. Huiwen H; Ji. Lin L; Yu. Yerong Y; Jiang. Sh...

In people with acromegaly, higher IGF‑1 levels were linked to more vertebral fractures, and a special CT scan (QCT) was better at spotting weak bones than the usual DXA scan. This suggests that too much IGF‑1 can hurt bone health, and standard bone density tests might miss the problem.

Browse All Studies